Introduction: This study examined the relative timing in individuals with dysarthria secondary to amyotrophic lateral sclerosis (ALS). The aim was to examine whether the relative timing was influenced by severity of dysarthria and phonetic complexity of the speech being produced. Methods: Twenty-one adults with dysarthria secondary to ALS, who presented with a range of dysarthria severity, participated in the study. A group of nonimpaired, age-matched adults served as controls. All participants produced a single phrase, across which four measures of relative timing were calculated, and the phonetic composition (complexity) of each measure was considered. Both participant groups completed the Sentence Intelligibility Test, which provided measures of speech intelligibility and speaking rate. Results: Relative timing did not significantly differ between speaker groups across the four measures, regardless of phonetic complexity. Neither Sentence Intelligibility Test score nor speaking rate were significantly correlated with relative timing. Discussion: Relative timing of phrase-level speech appears to remain intact regardless of the phonetic complexity of speech among individuals with dysarthria secondary to ALS. The potential of an internal phonological system organizing speech gestures is discussed to explain why the consistency in relative timing occurs.

1.
Tomik
B
,
Guiloff
RJ
.
Dysarthria in amyotrophic lateral sclerosis: a review
.
Amyotroph Lateral Scler
.
2010
;
11
(
1–2
):
4
.
2.
Goberman
AM
,
McMillan
J
.
Relative speech timing in Parkinson disease
.
CICSD
.
2005
;
32
:
22
.
3.
Robb
MP
,
Pang‐Ching
GK
.
Relative timing characteristics of hearing‐impaired speakers
.
J Acoust Soc Am
.
1992
;
91
(
5
):
2954
.
4.
Weismer
G
,
Fennell
AM
.
Constancy of (acoustic) relative timing measures in phrase-level utterances
.
J Acoust Soc Am
.
1985
;
78
(
1 Pt 1
):
49
57
.
5.
Allen
GD
.
Segmental timing control in speech production
.
J Phon
.
1973
;
1
(
3
):
219
37
.
6.
Kozhevnikov
VA
,
Christovich
LA
.
Speech: articulation and perception
.
Washington
:
Joint Publications Research Service
;
1965
.
7.
Franz
EA
,
Zelaznik
HN
,
Smith
A
.
Evidence of common timing processes in the control of manual, orofacial, and speech movements
.
J Motor Behav
.
1992
;
24
(
3
):
281
.
8.
Browman
CP
,
Goldstein
L
.
Articulatory phonology: an overview
.
Phonetica
.
1992
;
49
(
3–4
):
155
.
9.
Goldstein
L
,
Saltzman
E
,
Chitoran
I
,
Nam
H
.
Coupled oscillator model of speech timing and syllable structure coupled oscillator planning model of speech timing and syllable structure
.
Proceedings of the 8th Phonetic Conference of China and the International Symposium on Phonetic Frontiers in Phonetics and Speech Science, Beijing
,
2009
.
10.
White
L
.
Communicative function and prosodic form in speech timing
.
Speech Com
.
2014
;
63–64
:
38
.
11.
Prosek
RA
,
Montgomery
AA
,
Walden
BE
.
Constancy of relative timing for stutterers and nonstutterers
.
J Speech Lang Hear Res
.
1988
;
31
(
4
):
654
.
12.
Kent
RD
,
Forner
LL
.
Speech segment durations in sentence recitations by children and adults
.
J Phon
.
1980
;
8
:
157
68
.
13.
Ball
LJ
,
Beukelman
DR
,
Pattee
GL
.
Timing of speech deterioration in people with amyotrophic lateral sclerosis
.
J Med Speech Lang Pathol
.
2002
;
10
(
4
):
231
5
.
14.
Nishio
M
,
Niimi
S
.
Changes over time in dysarthric patients with amyotrophic lateral sclerosis (ALS): a study of changes in speaking rate and maximum repetition rate (MRR)
.
Clin Linguist Phonetics
.
2000
;
14
:
485
97
.
15.
Tjaden
K
,
Turner
G
.
Segmental timing in amyotrophic lateral sclerosis
.
J Speech Lang Hear Res
.
2000
;
43
(
3
):
683
.
16.
Turner
GS
,
Weismer
G
.
Characteristics of speaking rate in the dysarthria associated with amyotrophic lateral sclerosis
.
J Speech Lang Hear Res
.
1993
;
36
(
6
):
1134
.
17.
Ziegler
W
,
Hartmann
E
,
Hoole
P
.
Syllabic timing in dysarthria
.
J Speech Lang Hear Res
.
1993
;
36
(
4
):
683
.
18.
Weismer
G
,
Fennell
AM
.
Variability characteristics of segment and ratio measures of timing in normal and neurogenically disordered speakers
.
J Acoust Soc Am
.
1984
;
76
(
S1
):
S16
.
19.
Ludlow
CL
,
Connor
NP
,
Bassich
CJ
.
Speech timing in Parkinson’s and Huntington’s disease
.
Brain Lang
.
1987
;
32
(
2
):
195
214
.
20.
Lee
J
,
Dickey
E
,
Simmons
Z
.
Vowel-specific intelligibility and acoustic patterns in individuals with dysarthria secondary to amyotrophic lateral sclerosis
.
J Speech Lang Hear Res
.
2019
;
62
(
1
):
34
.
21.
Bhatia
A
,
Dorr
B
,
Hollingshead
K
,
Phillips
SL
,
McKenzie
B
.
Characterization of divergence in impaired speech of ALS patients
.
ACL Anthol
.
2017
;
2017
:
149
58
.
22.
Kent
R
.
The biology of phonological development
. In:
Ferguson
C
,
Menn
L
,
Stoel-Gammon
C
, editors.
Phonological development: models, research, implications
.
Timonium
:
York Press
;
1992
. p.
65
90
.
23.
Allison
KM
,
Hustad
KC
.
Impact of sentence length and phonetic complexity on intelligibility of 5-year-old children with cerebral palsy
.
Int J Speech Lang Pathol
.
2014
;
16
(
4
):
396
.
24.
Kim
H
,
Martin
K
,
Hasegawa-Johnson
M
,
Perlman
A
.
Frequency of consonant articulation errors in dysarthric speech
.
Clin Linguist Phon
.
2010
;
24
(
10
):
759
.
25.
Kuruvilla-Dugdale
M
,
Custer
C
,
Heidrick
L
,
Barohn
R
,
Govindarajan
R
.
A phonetic complexity-based approach for intelligibility and articulatory precision testing: a preliminary study on talkers with amyotrophic lateral sclerosis
.
J Speech Lang Hear Res
.
2018
;
61
(
9
):
2205
.
26.
Kuruvilla-Dugdale
M
,
Salazar
M
,
Zhang
A
,
Mefferd
AS
.
Detection of articulatory deficits in Parkinson’s disease: can systematic manipulations of phonetic complexity help?
J Speech Lang Hear Res
.
2020
;
63
(
7
):
2084
98
.
27.
Lee
J
,
Bell
M
,
Simmons
Z
.
Articulatory kinematic characteristics across the dysarthria severity spectrum in individuals with amyotrophic lateral sclerosis
.
Am J Speech Lang Pathol
.
2018
;
27
(
1
):
258
.
28.
Lee
J
,
Fischer
JC
.
Single word-based acoustic vowel space in individuals with dysarthria secondary to amyotrophic lateral sclerosis
.
Perspect ASHA Sigs
.
2019
;
4
(
5
):
1171
.
29.
Nasreddine
ZS
,
Phillips
NA
,
Bédirian
V
,
Charbonneau
S
,
Whitehead
V
,
Collin
I
,
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
.
J Am Geriatr Soc
.
2005
;
53
(
4
):
695
9
.
30.
Brooks
BR
,
Miller
RG
,
Swash
M
,
Munsat
TL
.
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
.
Amyotrophic Lateral Scler Other Motor Neuron Disord
.
2000
;
1
(
5
):
293
.
31.
Cedarbaum
JM
,
Stambler
N
,
Malta
E
,
Fuller
C
,
Hilt
D
,
Thurmond
B
,
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function
.
J Neurol Sci
.
1999
;
169
(
1–2
):
13
21
.
32.
Beukelman
DR
,
Yorkston
K
,
Hakel
M
,
Dorsey
M
.
Speech intelligibility test [Computer software]
.
Lincoln
:
Madonna Rehabilitation Hospital
;
2007
.
33.
Neel
AT
.
Effects of loud and amplified speech on sentence and word intelligibility in Parkinson disease
.
J Speech Lang Hear Res
.
2009
;
52
(
4
):
1021
33
.
34.
Tjaden
K
,
Sussman
JE
,
Wilding
GE
.
Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis
.
J Speech Lang Hear Res
.
2014
;
57
(
3
):
779
92
.
35.
Fairbanks
F
.
The rainbow passage voice and articulation drillbook
.
New York
:
Harper & Row
;
1960
.
36.
Katz
WF
,
Bharadwaj
SV
,
Stettler
MP
.
Influences of electromagnetic articulography sensors on speech produced by healthy adults and individuals with aphasia and apraxia
.
J Speech Lang Hear Res
.
2006
;
49
(
3
):
645
59
.
37.
Milenkovic
P
.
TF32
.
Madison
:
University of Wisconsin
;
2004
.
38.
Reddy
M
.
Statistical package for social sciences
. In:
Reddy
M
, editor.
Statistical methods in psychiatry research and SPSS
.
Waretown
:
Apple Academic Press
;
2014
.
39.
Kelso
JAS
,
Saltzman
EL
,
Tuller
B
.
The dynamical perspective on speech production: data and theory
.
J Phon
.
1986
;
14
:
29
59
.
40.
Weismer
G
,
Yunusova
Y
,
Westbury
JR
.
Interarticulator coordination in dysarthria: an X-ray microbeam study
.
J Speech Lang Hear Res
.
2003
;
46
(
5
):
1247
61
.
41.
Marin
S
,
Pouplier
M
.
Temporal organization of complex onsets and codas in American English: testing the predictions of a gestural coupling model
.
Motor Control
.
2010
;
14
(
3
):
380
407
.
42.
Esposito
A
,
Bourbakis
N
.
The role of timing in speech perception and speech production processes and its effects on language impaired individuals
. Sixth IEEE Symposium on BioInformatics and BioEngineering.
2006
;
2006
:
348
56
.
43.
Berwanger
D
,
Wittmann
M
,
Von Steinbüchel
N
,
Von Suchodoletz
W
.
Measurement of temporal-order judgment in children
.
Acta Neurobiol Exp
.
2004
;
64
(
3
):
387
94
.
44.
Santhosh
J
,
Bhatia
M
,
Sahu
S
,
Anand
S
.
Quantitative EEG analysis for assessment to “plan” a task in amyotrophic lateral sclerosis patients: a study of executive functions (planning) in ALS patients
.
Cogn Brain Res
.
2004
;
22
(
1
):
59
66
.
45.
Nevler
N
,
Ash
S
,
McMillan
C
,
Elman
L
,
McCluskey
L
,
Irwin
DJ
,
Automated analysis of natural speech in amyotrophic lateral sclerosis spectrum disorders
.
Neurology
.
2020
;
95
(
12
):
e1629
39
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.